{
    "username": "capitallgrowth",
    "likes": "123",
    "comments": "2",
    "date_posted": "April 4, 2025",
    "description": "With cancer treatments rapidly evolving nowadays, and the global cancer therapeutics market expected to reach half a trillion dollars by 2034, one small-cap biotech is stealing the spotlight with its game-changing approach to tackling tough cancers, and the company is Actuate Therapeutics, ticker A-C-T-U on NASDAQ, and this video is disseminated on their behalf.\n\nDisclaimer:\n\nThis video was produced on behalf of Actuate Therapeutics, Inc, and sponsored by the company. The influencer was compensated $2750 USD by Dadmin Capital LLC to create this content. This is not financial advice, and viewers are encouraged to consult a financial professional before making investment decisions. Investing in small-cap companies involves significant risks, and past performance does not guarantee future results. Please DYOR (do your own research)\". ",
    "hashtags": [],
    "platform": "Instagram"
}